ロード中...
Design of high-affinity major histocompatibility complex-specific antagonist peptides that inhibit cytotoxic T-lymphocyte activity: implications for control of viral disease.
Cytotoxic T lymphocytes (CTLs) recognize viral antigens presented by infected cells in the context of their major histocompatibility complex glycoproteins. The irreversible killing of virus-infected cells by virus-specific CTLs can be the cause of serious disease, particularly in the central nervous...
保存先:
主要な著者: | , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
1992
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC240172/ https://ncbi.nlm.nih.gov/pubmed/1383569 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|